Objective: Prospectively assess the performance of diffusion-weighted magnetic resonance imaging (DW-MRI) for differentiation of central lung cancer from atelectasis.
Introduction
Central bronchogenic tumors often cause post-obstructive pneumonia resulting in lung volume loss that can induce atelectasis [1] . Atelectasis and tumors both appear as solid dense shadows on standard radiography, so differentiation can be difficult. However, accurate characterization of the tumor is important for clinical staging, and differentiation of the tumor mass from atelectasis is important for CT-guided biopsy, setting of the radiation field for radiotherapy, and evaluation of therapeutic results. Therefore, computed tomography (CT) and magnetic resonance imaging (MRI) are often used together to differentiate lung cancer and atelectasis [2] [3] [4] [5] . New diagnostic approaches, such as the integration of MRI and PET images through image fusion software, are also becoming more popular [6] . However, this method can be expensive, is not routinely available, and involves exposure to additional radiation.
Rapid improvements in the hardware and software used for MRI have led to new potential approaches for MRI-based pulmonary imaging, such as diffusion-weighted (DW)-MRI. In DW-MRI, image contrast is a function of the rate of water diffusion, as indicated by the apparent diffusion coefficient (ADC), and this allows differentiation of normal and pathological tissues. DW-MRI has well-known clinical utility for the evaluation of intracranial diseases, such as early cerebral ischemia, white matter disorders, epilepsy, depression, dementia, and other brain diseases [7, 8] . Furthermore, developments of echo-planar imaging (EPI), high gradient amplitudes, multi-channel coils, and parallel imaging have reduced image distortion and increased the signalto-noise ratio (SNR), making whole-body DW-MRI more feasible.
The purpose of our current investigation was to prospectively evaluate the performance of DW-MRI in the differentiation of central lung carcinoma and accompanying atelectasis. 
Materials and Methods

Patient Characteristics
PET-CT Imaging
After fasting for 4-6 h, all patients were given intravenous 2-deoxy-2-( 18 F)fluoro-D-glucose (FDG, 744639.2 MBq, 20.1061.05 mCi). An uptake phase of 60 min was used prior to imaging. All patients were encouraged to void before scanning. Images were obtained from the head to the proximal thighs with a combined PET/CT scanner (Discovery ST; General Electric Medical Systems, Milwaukee, WI). The unenhanced CT scan first was performed from the patient's head to the proximal thighs. Immediately after this, and without changing the patient's position, the tabletop moved automatically to the PET position. This scan was acquired starting at the mid thighs toward the head, for 6-7 bed positions of 4 min each. CT images were used to generate the transmission maps for attenuation correction of the PET acquisitions. PET data were reconstructed using an orderedsubset expectation maximization iterative algorithm as instructed by the PET device.
Thoracic MR Imaging
All MRI examinations were performed with a clinical scanner (Signa Infinity with EXCITE 1.5T System, GE Healthcare, Milwaukee, WI, USA) using a four-channel body phased-array coil. MRI was performed within 1-2 weeks after PET-CT while patients were still hospitalized. All patients were in the supine position throughout examinations. The MR scanning sequences were SE T1WI, FRFSE T2WI, FIESTA, and DW-MRI. All sequences used respiratory gating and electrocardiogram gating. 
Imaging Evaluation and Diagnostic Criteria
All PET/CT and MR images were independently analyzed by two senior radiologists. If these radiologists disagreed, a third senior radiologist was consulted until a consensus was reached. Image analysis involved assessment and comparison of FDG uptake (PET/CT images) and signal density (MR images) of central lung carcinoma and atelectasis.
Distinguishable cases are those in which differentiation of lung tumor and atelectasis was possible, and indistinguishable cases are those in which differentiation was not possible. In the evaluation of DW-MR images, cases in which the tumor had obvious hyperintensity relative to the atelectasis were considered distinguishable, and cases in which the signal of the atelectasis was continuous with the tumor were indistinguishable.
In each patient, evaluation of conventional MR and DW-MR images was performed with regions of interest (ROIs) from three different locations. ROIs were drawn and placed on the masses, atelectasis, and background, with exclusion of necrotic areas. Signal intensities of the ROIs were measured, and the contrast-tonoise ratio (CNR) of the tumor and atelectasis on conventional T2W and DW-MR images were calculated according to the following equation: CNR = |SI cancer -SI atelectasis |/SD where SI cancer is the signal intensity of central lung cancer, SI atelectasis is the signal intensity of the atelectasis, and SD is the standard deviation of the background noise.
The ADC maps were automatically reconstructed for all DW-MR images by the GE AW4.2 workstation. ADC values of each ROI were also measured on the ADC maps. Statistical Analysis
All numerical data are presented as box plots. The MannWhitney test was used for comparisons of CNR values from conventional T2W and DW-MR images, mean ADC values of the cancer and atelectasis, and ADC values of different histological types of lung cancers. All data were analyzed using SPSS 15.0 Table 1 summarizes the clinical characteristics of the 38 enrolled lung cancer patients. A lesion was present in the left upper lobe of 16 patients, in the left inferior lobe of 8 patients, in the right upper lobe of 9 patients, and in the right inferior lobe of 5 patients. Sixteen patients had squamous cell carcinoma, 13 patients had adenocarcinoma, and 9 patients had small cell lung carcinoma. Histological diagnosis was obtained by trans-bronchial aspiration biopsy in 26 cases and by CT-guided biopsy in 12 cases. Figures 1, 2 and 3 show representative PET/CT and MR images. PET/CT imaging indicated that tumor masses had more FDG uptake than the atelectasis in all 38 patients, making them easily distinguishable (Fig. 1a, 2a) . In contrast, the T1W MR images did not allow differentiation of tumor and atelectasis in any of the 38 patients (Fig. 1b, 2b) . Conventional T2W images allowed differentiation of lung cancer and atelectasis in 76% of cases (29/ 38) (Fig. 1c, 1d, 2c, 2d, 3a, 3b ). Among these 29 distinguishable cases, the signal intensity of the tumor was lower than the atelectasis in 28 cases (Fig. 1c, 1d, 2c, 2d) , and higher than the atelectasis in one case (Fig. 3a, 3b) . DW-MR images allowed easy differentiation of tumor and atelectasis in all 38 patients, and the tumor had higher signal intensity in all cases (Fig. 1e, 2e, 3c,) . In addition, ADC maps clearly showed that the central lung carcinoma had lower mean ADC (indicated by hyperintensity) (Fig. 1f, 2f, 3d) .
Results
Clinical Characteristics of Patients
PET/CT and MR Imaging of Central Lung Carcinoma and Atelectasis
CNR of Cancer and Atelectasis on Conventional T2W and DW-MR Images
The CNR of DW-MR images were clearly better than those from the conventional FRFSE T2WI and FIESTA MR images (p,0.0001 for both) (Figure 4a) . However, the CNR values of the different histologic types of central lung carcinoma were not significantly different under these 3 methods (Figure 4b-d) .
ADC Mapping of Cancer and Atelectasis
With a b-value of 500 s/mm 2 , the mean ADC for the central lung carcinoma was significantly less than that of the atelectasis (1.8360.58 vs. 2.9060.26 mm 2 /s, p,0.0001) (Figure 5a) . Analysis of the different histologic types of central lung carcinomas indicated that the mean ADC of small cell lung carcinoma was significantly greater than those from squamous cell carcinoma and adenocarcinoma (p,0.0001 for both) (Figure 5b ), but that squamous cell carcinoma and adenocarcinoma were not significantly different from each other.
Discussion
We prospectively evaluated the performance of DW-MR imaging for the differentiation of central lung cancer and atelectasis in 38 consecutive lung cancer patients from three institutions and compared the performance of this method with conventional MR imaging and PET/CT imaging. PET/CT imaging and DW-MR both provided differentiation of tumor and atelectasis in all 38 patients, but conventional MR imaging did not perform as well. Thus, DW-MR imaging provides valuable information not obtained by conventional MR and has potential for clinical differentiation of central lung carcinoma from atelectasis. Atelectasis is common in patients with central lung tumors. Lung cancer is routinely treated by surgery, radiation therapy, or chemotherapy, alone or in combination. Thus, differentiation of the tumor and atelectasis is important for assessment of the size and other characteristics of the tumor and for identification of tumor location, which is necessary for biopsy and targeted radiotherapy [2] .
CT is the most widely available and commonly used noninvasive imaging method for patients with thoracic diseases. Previous studies indicated that dynamic enhanced CT scanning can differentiate tumor from atelectasis in about 80% of cases [5] . However, bolus-enhanced CT performs poorly in the differentiation of tumor and atelectasis [1] . PET/CT allows evaluation of the metabolism of endobronchial lesions [9] , with increased FDG uptake at the site of obstruction, but this method is expensive and involves exposure to additional radiation.
Magnetic resonance imaging (MRI) is widely used and is a promising technique for tumor imaging because it does not employ ionizing radiation and it provides excellent soft tissue contrast and high spatial resolution [10, 11] . Tobler [5] retrospectively analyzed the ability of conventional MRI to distinguish atelectasis from tumors in the presence of a central bronchogenic carcinoma in 18 patients. Their results indicated that the T2W imaging sequences were much more informative than the T1W imaging sequences. This agrees with our results, in which T2W provided differentiation of tumor and atelectasis in 29 of 38 cases (76%), but T1W provided no such differentiation.
DW-MR imaging provides information on the molecular diffusion of water within tissues [2, [12] [13] [14] . This method can be performed quickly, there is no need for administration of exogenous contrast medium [15, 16] , it yields information indicative of changes at the cellular level, and it provides unique insights about tumor cellularity and the integrity of cell membranes [15, 17] . Recent advances allow this technique to be used for tumor detection and characterization, distinguishing of tumor tissue from non-tumor tissue, and monitoring and predicting of treatment response.
DW-MR imaging of the lung must be included in the measurement of true whole-body DW-MR imaging [18, 19] . Nonetheless, following the improvement of the echo-planar technique, DW echo planar MR imaging with its speed and relatively high signal-to-noise ratio, can be successfully performed in thoracic lesions [15] . The signal intensity provided by DW-MR imaging can characterize tissue and provide information about cellular density. In addition, the ADC is associated with the cellular density of tumor, and reduced ADC occurs in most malignant tumors [13] . Our DW-MR images indicated that the central lung carcinoma had a hyper-intense signal relative to the atelectasis in all 38 cases. Our results also indicated that the CNR of DW-MR images were significantly higher than those from conventional T2W images. The increased contrast between cancer and atelectasis readily allowed visualization of the lung tumor.
The mean ADC is expected to be lower in viable tumor tissue, which is densely packed, than in tissues with less densely packed obstacles, such as tumor necrosis or benign tissue [20, 21] . Baysal et al [6] [6] . In our study, the mean ADC values of the atelectasis were lower, but the mean ADC values of both the central lung carcinoma and atelectasis were still significantly different. Matoba et al [21] prospectively evaluated DW MR imaging for characterization of lung carcinomas by use of the ADC, and reported that the mean ADC of adenocarcinomas was significantly higher than that of squamous cell carcinomas and large-cell carcinomas, and that the mean ADC value of well-differentiated adenocarcinomas was significantly higher than that of poorly differentiated adenocarcinomas. In contrast, our results indicated that small cell carcinoma had higher mean ADC than adenocarcinoma and squamous cell carcinoma. Thus, our results disagree with those of Matoba et al [22] but are consistent with those of with Baysal et al [6] .
However, the ability of DW-MR imaging to be used for evaluation of thoracic lesions is hindered by image distortion because of its susceptibility to artifacts, including chemical shift artifacts, ghosts in the phase encoding direction, and respiratory and cardiac motions. Further studies are necessary to further assess the usefulness of DW-MR imaging and to determine whether DW-MR imaging can be used in clinical practice for the differentiation of central lung carcinoma and the accompanying atelectasis.
Conclusion
In conclusion, the results of this study indicate that DW-MR imaging may be useful for the differentiation of central lung carcinoma and accompanying atelectasis. Although our sample size was relatively small, our results indicate that evaluation of DW-MR signal intensity distribution and ADC maps may aid in the choice of biopsy site and selection of the field to be used for radiotherapy. 
